Label Image (Lbl500907888)
Losartan Potassium Tablet, Film Coated
Product Images NDC 50090-7888
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-7888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Losartancamberlogo (Losartancamberlogo)
Losartanfigure1 (Losartanfigure1)
This text presents information related to a study comparing the medications Atenolol and Losartan potassium. The study shows a Z Adjusted Risk Reduction of 13% with a p-value of 0.021. The study appears to have been conducted over a period of 60 months.*
Losartanfigure2 (Losartanfigure2)
Losartanfigure3 (Losartanfigure3)
This is information related to a clinical trial comparing the effects of Losartan Potassium and Atenolol in reducing the incidence of primary composite stroke (fatal/non-fatal). The results are based on different subgroups such as age, gender, race, hypertension (ISH), diabetes, and history of cardiovascular disease (CVD). The data includes the number of events, event rates, and hazard ratios with corresponding confidence intervals for each subgroup. The trial overall involved 9193 patients.*
Losartanfigure4 (Losartanfigure4)
This is a chart showing the risk reduction percentage of 16.1% with a p-value of 0.022 over a time frame ranging from 0 to 48 months. The study compares the effects of Losartan Potassium versus Placebo.*
Losartanstructure (Losartanstructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
